Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
exopolysaccharides from Pseudomonas aeruginosa AG01
- Development stage
- Unknown
- Lead developer
- Ain Shams University
01
Overview
Exopolysaccharides from Pseudomonas aeruginosa AG01 is an early-stage research compound being investigated for its potential therapeutic applications. This exopolysaccharide (EPS) is a biologic/polysaccharide produced by the bacterial strain Pseudomonas aeruginosa AG01. Academic studies have shown that the compound possesses potential antioxidant, antimicrobial, antibiofilm, antitumor, and antiviral properties. It is a complex polysaccharide containing functional groups such as amino groups, amides, carboxylic acids, hydroxyl groups, and phosphates. Researchers are exploring its use in anti-reflux treatments, drug delivery systems, and for medical applications like wound dressings to promote hemostasis and in dental impressions. To date, no specific biological target has been identified, and no pharmaceutical company has been reported to be commercially developing this compound.
- Other names
- exopolysaccharides from Pseudomonas aeruginosa AG01
Beyond the preview
Go deeper on exopolysaccharides from Pseudomonas aeruginosa AG01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on exopolysaccharides from Pseudomonas aeruginosa AG01.